Arizona Alzheimer's Disease Core Center
亚利桑那州阿尔茨海默病核心中心
基本信息
- 批准号:8174017
- 负责人:
- 金额:$ 163.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This grant application requests five years of renewed support for the Arizona Alzheimer's Disease Core Center (ADCC). The ADCC is intended to optimize the development and use of its Cores, advance the scientific understanding, unusually early detection, and tracking of AD, and the accelerated evaluation of AD modifying and prevention therapies, promote additional organizational investments, and provide a model of statewide collaboration in AD research. The Administrative Core provides the leadership and support needed to optimize the development, interactions, and use of its Cores. It works closely with researchers inside and outside Arizona, the National Alzheimer's Coordinating Center (NACC), and other AD Centers to promote the development and progress of AD-related studies and collaborations. It administers a program for the statewide solicitation, competitive review, and support of pilot studies. It helps solve the challenges and fulfill the opportunities associated with the ADCC's statewide collaborative model and ensures the ADCC's accountability to the NIA. The Clinical Core maintains a large pool of clinically well characterized and annually assessed research subjects for the scientific study of AD and aging, including patients with AD, other dementias, and mild cognitive impairment (MCI); normal controls, most of whom are enrolled in a brain donation program, and a growing number of Latino and Native American research subjects. This Core ensures the comparability and the productive and appropriate use of subjects, DNA, blood samples, and data from its six clinical sites. It also promotes the productive and appropriate scientific use of subjects from its independently supported APOE, Brain and Body Donation, and Clinical Therapeutics Registry Programs. The Data Management and Statistics Core maintains the ADCC's database, helps ensure the quality of data and the protection of subject confidentiality, and provides statistical services and image-analysis resources in a manner that best serves the needs of the statewide ADCC. It works closely with researchers, NACC, and other AD Centers, sharing data in the most productive, timely, and appropriate way. The Neuropathology Core provides neuropathological diagnoses and extremely high-quality brain and body tissues from expired Clinical Core and ancillary program subjects to support research studies in Arizona and around the world, helping to address a critical need in the AD research community. The Education and Information Core provides training, innovative educational and outreach programs, and strategic partnerships to promote the development of AD-related researchers, address needs of professional and family caregivers, provide information about the ADCC, address unmet needs of Arizona's Native American and rapidly growing Latino communities, and assist in the Clinical Core enrollment and study of these understudied groups.
该赠款申请要求对亚利桑那州阿尔茨海默氏病核心中心(ADCC)的五年重新支持。 ADCC旨在优化其核心的开发和使用,提高科学理解,异常的早期检测和对AD的跟踪以及对AD修改和预防疗法的加速评估,促进更多的组织投资,并提供全州范围的AD研究模型。行政核心提供了优化核心发展,互动和使用所需的领导和支持。它与亚利桑那州内外的研究人员,国家阿尔茨海默氏症协调中心(NACC)和其他广告中心紧密合作,以促进与广告相关的研究和合作的发展和进步。它管理一项计划,用于全州招标,竞争性审查和对试点研究的支持。它有助于解决挑战并实现与ADCC全州协作模型相关的机会,并确保ADCC对NIA的问责制。临床核心维持大量临床表征和每年评估的研究对象,以进行AD和衰老的科学研究,包括AD,其他痴呆症和轻度认知障碍(MCI);正常的控制,大多数人都参加了大脑捐赠计划,以及越来越多的拉丁裔和美国原住民研究对象。该核心确保了来自六个临床部位的受试者,DNA,血液样本和数据的可比性和生产性和适当使用。它还促进了其独立支持的APOE,大脑和身体捐赠以及临床治疗仪式计划中对受试者的富有成效和适当的科学使用。数据管理和统计核心维护ADCC的数据库,有助于确保数据质量和对主题机密性的保护,并以最能满足全州范围ADCC需求的方式提供统计服务和图像分析资源。它与研究人员,NACC和其他广告中心紧密合作,以最有生产力,及时和适当的方式共享数据。神经病理学核心提供神经病理学诊断,并从过期的临床核心和辅助计划主题中提供了极高的大脑和身体组织,以支持亚利桑那州及世界各地的研究,从而帮助满足AD研究社区的关键需求。教育和信息核心提供培训,创新的教育和外展计划以及战略伙伴关系,以促进与广告相关的研究人员的发展,满足专业和家庭护理人员的需求,提供有关ADCC的信息,有关ADCC的信息,满足亚利桑那州原住民的未满足需求以及快速发展的拉丁裔社区的需求,以及在这些被挖掘的研究小组的临床核心注册和研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
ERIC MICHAEL REIMA...的其他基金
Arizona Alzheimer's Disease Research Center
亚利桑那州阿尔茨海默病研究中心
- 批准号:1026418710264187
- 财政年份:2021
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Arizona Alzheimer's Disease Research Center
亚利桑那州阿尔茨海默病研究中心
- 批准号:1065648810656488
- 财政年份:2021
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Alzheimer's Prevention Initiative APOE4 Trial
阿尔茨海默病预防计划 APOE4 试验
- 批准号:86052978605297
- 财政年份:2013
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Cyclotron, PET and MRI Facility Improvement: A Scientific Resource for Arizona
回旋加速器、PET 和 MRI 设施改进:亚利桑那州的科学资源
- 批准号:78984997898499
- 财政年份:2010
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
The GE PETtrace Cyclotron: A Scientific Resource for the State of Arizona
GE PETtrace 回旋加速器:亚利桑那州的科学资源
- 批准号:78401697840169
- 财政年份:2010
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Arizona Alzheimer's Disease Core Center
亚利桑那州阿尔茨海默病核心中心
- 批准号:81183618118361
- 财政年份:2010
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
PET, APOE & the Preclinical Course of Alzheimer's Disease
宠物、载脂蛋白
- 批准号:80500448050044
- 财政年份:2008
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
PET, APOE & the Preclinical Course of Alzheimer's Disease
宠物、载脂蛋白
- 批准号:75969247596924
- 财政年份:2008
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
PET, APOE & the Preclinical Course of Alzheimer's Disease
宠物、载脂蛋白
- 批准号:73834337383433
- 财政年份:2008
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
相似国自然基金
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
- 批准号:82372073
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
藤黄科植物中多靶点抗痴呆症天然先导化合物及其作用机制研究
- 批准号:31770379
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
BDNF前肽片段调控Alzheimer疾病模型海马gamma振荡的突触环路机制研究
- 批准号:81701070
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
神经元轴突起始节异常在老年性痴呆症的发生发展中的作用
- 批准号:31630028
- 批准年份:2016
- 资助金额:267.0 万元
- 项目类别:重点项目
阿尔茨海默病神经免疫系统异常的机制研究
- 批准号:31530089
- 批准年份:2015
- 资助金额:285.0 万元
- 项目类别:重点项目
相似海外基金
Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease
联合估计扩散成像 (JEDI) 可改善衰老和阿尔茨海默病的组织表征和神经连接
- 批准号:1066291110662911
- 财政年份:2023
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
- 批准号:1081932910819329
- 财政年份:2023
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:1076694710766947
- 财政年份:2023
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Leadership and Administrative Core
领导和行政核心
- 批准号:1073013110730131
- 财政年份:2023
- 资助金额:$ 163.2万$ 163.2万
- 项目类别:
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:1083688010836880
- 财政年份:2023
- 资助金额:$ 163.2万$ 163.2万
- 项目类别: